Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 1, 2016, Pages 37-43

  Fontana, V ^a   Santinelli, S ^a   Internullo, M ^a   Marinelli, P ^a   Sardo, L ^a   Alessandrini, G ^a   Borgognoni, L ^a   Ferrazza, A M ^a   Bonini, M ^a   Palange, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetazolamide; AECOPD; Medical ward; Metabolic alkalosis; NIV

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; AIRWAY PRESSURE; ARTERIAL PH; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; HUMAN; HYPERCAPNIA; METABOLIC ALKALOSIS; MORNING DOSAGE; NONINVASIVE VENTILATION; RESPIRATORY FAILURE; STANDARD; URINE PH; ACID BASE BALANCE; ADVERSE EFFECTS; AGED; ALKALOSIS; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME; VERY ELDERLY;

ACETAZOLAMIDE; ACID-BASE EQUILIBRIUM; ACUTE DISEASE; AGED; AGED, 80 AND OVER; ALKALOSIS; CARBONIC ANHYDRASE INHIBITORS; FEMALE; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; NONINVASIVE VENTILATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84957945207     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LOPEZ AD, SHIBUYA K, RAO C, MATHERS CD, HANSELL AL, HELD LS, SCHMID V, BUIST S. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
2. GUNEN H, HACIEVLIYAGIL SS, KOSAR F, MUTLU LC, GULBAS G, PEHLIVAN E, SAHIN I, KIZKIN O. Factors affecting survival of hospitalised patients with COPD Eur Respir J 2005; 26: 234-241.
3. COOPER CB, HOWARD P. An analysis of sequential physiologic changes in hypoxic cor pulmonale during long-term oxygen therapy. Chest 1991; 100: 76-80.
4. REPORT OF THE MEDICAL RESEARCH COUNCIL WORKING PARTY. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686.
5. FOUCHER P, BAUDOUIN N, MERATI M, PITARD A, BONNIAUD P, REYBET-DEGAT O, JEANNIN L. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998; 113: 1580-1587.
6. AIDA A, MIYAMOTO K, NISHIMURA M, AIBA M, KIRA S, KAWAKAMI Y. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med 1998; 158: 188-193.
7. BRITISH THORACIC SOCIETY STANDARDS OF CARE COMMITTEE, Non-invasive ventilation in acute respiratory failure. Thorax 2002; 57: 192-211.
8. PLANT PK, OWEN JL, ELLIOTT MW. Early use of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: 1931-1935.
9. LIGHTOWLER JV, WEDZICHA JA, ELLIOTT MW, RAM FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Br Med J 2003; 326: 185-187.
10. KOBAYASHI S, NISHIMURA M, YAMOMOTO M, AKIYAMA Y, MIYAMOTO K, KAWAMAKI Y. Relationship between breathlessness and hypoxic and hypercapnic ventilatory response in patients with COPD. Eur Respir J 1996; 9: 2340-2345.
11. KHANNA A, KURTZMAN NA. Metabolic alkalosis. Respir Care 2001; 46: 354-365.
12. HODGKIN JE, SOEPRONO FF, CHAN DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med 1980; 8: 725-728.
13. BERTHELSEN P. Cardiovascular performance and oxyhemoglobin dissociation after acetazolamide in metabolic alkalosis. Intensive Care Med 1982; 8: 269-274.
14. BEAR R, GOLDSTEIN M, PHILLIPSON E, HO M, HAMMEKE M, FELDMAN R, HANDELSMAN S, HALPERIN M. Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. Can Med Assoc J 1977; 117: 900-903.
15. HEMING N, FAISY C, URIEN S. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients. Crit Care 2011; 15: R213.
16. TEPPEMA LJ, DAHAN A. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med 1999; 160: 1592-1597.
17. SWENSON ER. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 1998; 12: 1242-1247.
18. FAISY C, MOKLINE A SANCHEZ O, TADIÉ JM, FAGON JY. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med 2010; 36: 859-863.
19. JONES PW, GREENSTONE M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2001; 1: CD002881.